Journal of Medical Economics, Volume 17, Issue 4 (2014)

Browse this journal
Sample our Medicine, Dentistry, Nursing & Allied Health journals, sign in here to start your FREE access for 14 days

Journal of Medical Economics, Volume 17, Issue 4 (2014)

See all volumes and issues
Vol 27, 2024 Vol 26, 2023 Vol 25, 2022 Vol 24, 2021 Vol 23, 2020 Vol 22, 2019 Vol 21, 2018 Vol 20, 2017 Vol 19, 2016 Vol 18, 2015 Volume 17, 2014 Vol 16, 2013 Vol 15, 2012 Vol 14, 2011 Vol 13, 2010 Vol 12, 2009 Vol 11, 2008 Vol 10, 2007 Vol 9, 2006 Vol 8, 2005 Vol 7, 2004 Vol 6, 2003 Vol 5, 2002 Vol 4, 2001 Vol 3, 2000 Vol 2, 1999 Vol 1, 1998
Download citations Download PDFs Download issue

Oncology: Original article

Article
A cost–utility analysis of degarelix in the treatment of advanced hormone-dependent prostate cancer in the United Kingdom
Dawn Lee, Joshua Porter, Daniel Gladwell, Nic Brereton & Sandy K. Nielsen
Pages: 233-247
Published online: 25 Feb 2014
AbstractforA cost–utility analysis of degarelix in the treatment of advanced hormone-dependent prostate cancer in the United Kingdom | Full Text | References | PDF (940.1 KB) | Supplemental
  • 1416 Views
  • 10 CrossRef citations
  • 0Altmetric
Free Access

Letter to the Editor

Letter
Letter to the Editor
Vakaramoko Diaby, Georges Adunlin & Alberto J. Montero
Pages: 248-249
Published online: 20 Feb 2014
CitationforLetter to the Editor | Full Text | References | PDF (54.2 KB)
  • 587 Views
  • 0 CrossRef citations
  • 0Altmetric
Free Access

Infectious Disease: Original article

Article
Cost-minimization comparison of darunavir plus ritonavir and lopinavir/ritonavir in HIV-1 infected treatment-naïve women of childbearing age
Jörgen Möller, Kamal Desai, Kit Simpson, Robert W. Baran, Olivier Van de Steen, Birgitta Dietz & Katherine Gooch
Pages: 250-258
Published online: 20 Feb 2014
AbstractforCost-minimization comparison of darunavir plus ritonavir and lopinavir/ritonavir in HIV-1 infected treatment-naïve women of childbearing age | Full Text | References | PDF (256.4 KB) | Supplemental
  • 435 Views
  • 1 CrossRef citations
  • 0Altmetric
Free Access

Rheumatology: Original article

Article
Switching of biologic disease modifying anti-rheumatic drugs in patients with rheumatoid arthritis in a real world setting
Brian Meissner, Digisha Trivedi, Min You & Lisa Rosenblatt
Pages: 259-265
Published online: 27 Feb 2014
AbstractforSwitching of biologic disease modifying anti-rheumatic drugs in patients with rheumatoid arthritis in a real world setting | Full Text | References | PDF (531.3 KB) | Supplemental
  • 1089 Views
  • 36 CrossRef citations
  • 0Altmetric
Free Access

Orthopedics: Original article

Article
Economic evaluation of BST-CarGel as an adjunct to microfracture vs microfracture alone in knee cartilage surgery
Julie Frappier, William Stanish, Mats Brittberg, Matthias Steinwachs, Lydia Crowe, David Castelo & Alberto Restrepo
Pages: 266-278
Published online: 06 Mar 2014
AbstractforEconomic evaluation of BST-CarGel as an adjunct to microfracture vs microfracture alone in knee cartilage surgery | Full Text | References | PDF (365 KB)
  • 994 Views
  • 18 CrossRef citations
  • 0Altmetric
Free Access

Pain: Original article

Article
Medical cost savings associated with an extended-release opioid with abuse-deterrent technology in the US
Louis F. Rossiter, Noam Y. Kirson, Amie Shei, Alan G. White, Howard G. Birnbaum, Rami Ben-Joseph & Edward Michna
Pages: 279-287
Published online: 07 Mar 2014
AbstractforMedical cost savings associated with an extended-release opioid with abuse-deterrent technology in the US | Full Text | References | PDF (112.4 KB)
  • 2904 Views
  • 31 CrossRef citations
  • 0Altmetric
Free Access

Endocrinology: Original article

Article
Budget impact of pasireotide for the treatment of Cushing’s disease, a rare endocrine disorder associated with considerable comorbidities
H. L. Truong, D. Nellesen, W. H. Ludlam & M. P. Neary
Pages: 288-295
Published online: 11 Mar 2014
AbstractforBudget impact of pasireotide for the treatment of Cushing’s disease, a rare endocrine disorder associated with considerable comorbidities | Full Text | References | PDF (227.1 KB) | Supplemental
  • 1698 Views
  • 7 CrossRef citations
  • 0Altmetric
Free Access

Psychiatry: Original article

Article
Cost-effectiveness of asenapine in the treatment of schizophrenia in Canada
Jean Lachaine, Catherine Beauchemin, Karine Mathurin, Dominique Gilbert & Maud Beillat
Pages: 296-304
Published online: 11 Mar 2014
AbstractforCost-effectiveness of asenapine in the treatment of schizophrenia in Canada | Full Text | References | PDF (174.1 KB)
  • 1098 Views
  • 5 CrossRef citations
  • 0Altmetric
Free Access

Explore articles

Explore the most recently published articles

Impact of Pseudomonas aeruginosa on resource utilization and costs in patients with exacerbated non-cystic fibrosis bronchiectasis
Meg Franklin et al.
Article | Published online: 27 Apr 2024
Open Access
Cost-effectiveness of rimegepant oral lyophilisate compared to best supportive care for the acute treatment of migraine in the UK
Karissa Johnston et al.
Article | Published online: 27 Apr 2024
Open Access
Costs associated with adverse events during treatment episodes for adult attention-deficit/hyperactivity disorder
Jeff Schein et al.
Article | Published online: 27 Apr 2024
Open Access
Value-based payment and financing for cell and gene therapies: challenges and potential solutions
James X. Zhang et al.
Editorial | Published online: 27 Apr 2024
Open Access
View all latest articles